Key facts
- It has raised $11.2M; the latest was Later Stage VC ($7.7M) in Sep 2025.
- Notable investors include James Hawkes, K. Pinard Trust, Richard Pierro, Sotirios Pappas.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for MiRTLE
- ·The full record, as it builds
Funding rounds
No funding rounds for MiRTLE are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MiRTLE
Developer of a medical device designed to help cardiologists, electrophysiologists, and radiologists. The company provides medical devices and software alternatives for cardiac monitoring inside magnetic resonance imaging while expanding clinical and operational procedures to improve patient outcomes, enabling medical professionals to have access to vital patient health information throughout the imaging process.
- Sector
- Healthcare
- HQ
- North Andover, MA, United States
- Founded
- 2012
- Employees
- 4
- Website
- mirtlemed.com/
- Ownership
- Privately Held (backing)
MiRTLE doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MiRTLE shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MiRTLE in its N-PORT filings yet. We sweep new filings monthly.